Summary
Global Heparin Market 2021-2025
Technavio has been monitoring the heparin market and it is poised to grow by $ 2.29 bn during 2021-2025, progressing at a CAGR of about 6% during the forecast period. Our report on the heparin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of coagulation disorders and the increasing prevalence of chronic conditions. In addition, the increasing prevalence of coagulation disorders is anticipated to boost the growth of the market as well.
The heparin market analysis includes product and route of administration segments and geographic landscape.
Technavio's heparin market is segmented as below:
By Product
Low-molecular-weight heparin
Others
By Route of Administration
Subcutaneous injection
Intravenous/infusion
By Geography
Europe
North America
Asia
ROW
This study identifies the reintroduction of alternative sources to produce heparin as one of the prime reasons driving the heparin market growth during the next few years.
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on heparin market covers the following areas:
Heparin market sizing
Heparin market forecast
Heparin market industry analysis
Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading heparin market vendors that include Aspen Pharmacare Holdings Ltd., Baxter International Inc., Eisai Co. Ltd., Fresenius SE and Co. KGaA, Hikma Pharmaceuticals Plc, Laboratorios Farmaceuticos Rovi SA, Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd., Pfizer Inc., Sanofi SA, and Viatris Inc. Also, the heparin market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/heparin-market-industry-analysis
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
ページTOPに戻る
Table of Contents
Executive Summary
Market overview
Market Landscape
Market ecosystem
Value chain analysis
Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
Market Segmentation by Product
Market segments
Comparison by Product
Low-molecular-weight heparin - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by Product
Market Segmentation by Route of administration
Market segments
Comparison by Route of administration
Subcutaneous injection - Market size and forecast 2020-2025
Intravenous/infusion - Market size and forecast 2020-2025
Market opportunity by Route of administration
Customer landscape
Customer landscape
Geographic Landscape
Geographic segmentation
Geographic comparison
Europe - Market size and forecast 2020-2025
North America - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends
Vendor Landscape
Overview
Landscape disruption
Vendor Analysis
Vendors covered
Market positioning of vendors
Aspen Pharmacare Holdings Ltd.
Baxter International Inc.
Eisai Co. Ltd.
Fresenius SE and Co. KGaA
Hikma Pharmaceuticals Plc
Laboratorios Farmaceuticos Rovi SA
Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd.
Pfizer Inc.
Sanofi SA
Viatris Inc.
Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations
zzzz
Exhibits1: Key Finding 1
Exhibits2: Key Finding 2
Exhibits3: Key Finding 3
Exhibits4: Key Finding 5
Exhibits5: Key Finding 6
Exhibits6: Key Finding 7
Exhibits7: Key Finding 8
Exhibits8: Key Finding 9
Exhibits9: Parent market
Exhibits10: Market characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Global - Market size and forecast 2020 - 2025 ($ million)
Exhibits14: Global market: Year-over-year growth 2020 - 2025 (%)
Exhibits15: Five forces analysis 2020 & 2025
Exhibits16: Bargaining power of buyers
Exhibits17: Bargaining power of suppliers
Exhibits18: Threat of new entrants
Exhibits19: Threat of substitutes
Exhibits20: Threat of rivalry
Exhibits21: Market condition - Five forces 2020
Exhibits22: Product - Market share 2020-2025 (%)
Exhibits23: Comparison by Product
Exhibits24: Low-molecular-weight heparin - Market size and forecast 2020-2025 ($ million)
Exhibits25: Low-molecular-weight heparin - Year-over-year growth 2020-2025 (%)
Exhibits26: Others - Market size and forecast 2020-2025 ($ million)
Exhibits27: Others - Year-over-year growth 2020-2025 (%)
Exhibits28: Market opportunity by Product
Exhibits29: Route of administration - Market share 2020-2025 (%)
Exhibits30: Comparison by Route of administration
Exhibits31: Subcutaneous injection - Market size and forecast 2020-2025 ($ million)
Exhibits32: Subcutaneous injection - Year-over-year growth 2020-2025 (%)
Exhibits33: Intravenous/infusion - Market size and forecast 2020-2025 ($ million)
Exhibits34: Intravenous/infusion - Year-over-year growth 2020-2025 (%)
Exhibits35: Market opportunity by Route of administration
Exhibits36: Customer landscape
Exhibits37: Market share by geography 2020-2025 (%)
Exhibits38: Geographic comparison
Exhibits39: Europe - Market size and forecast 2020-2025 ($ million)
Exhibits40: Europe - Year-over-year growth 2020-2025 (%)
Exhibits41: North America - Market size and forecast 2020-2025 ($ million)
Exhibits42: North America - Year-over-year growth 2020-2025 (%)
Exhibits43: Asia - Market size and forecast 2020-2025 ($ million)
Exhibits44: Asia - Year-over-year growth 2020-2025 (%)
Exhibits45: ROW - Market size and forecast 2020-2025 ($ million)
Exhibits46: ROW - Year-over-year growth 2020-2025 (%)
Exhibits47: Key leading countries
Exhibits48: Market opportunity by geography ($ million)
Exhibits49: Impact of drivers and challenges
Exhibits50: Vendor landscape
Exhibits51: Landscape disruption
Exhibits52: Industry risks
Exhibits53: Vendors covered
Exhibits54: Market positioning of vendors
Exhibits55: Aspen Pharmacare Holdings Ltd. - Overview
Exhibits56: Aspen Pharmacare Holdings Ltd. - Business segments
Exhibits57: Aspen Pharmacare Holdings Ltd. - Key offerings
Exhibits58: Aspen Pharmacare Holdings Ltd. - Key customers
Exhibits59: Aspen Pharmacare Holdings Ltd. - Segment focus
Exhibits60: Baxter International Inc. - Overview
Exhibits61: Baxter International Inc. - Business segments
Exhibits62: Baxter International Inc. - Key offerings
Exhibits63: Baxter International Inc. - Key customers
Exhibits64: Baxter International Inc. - Segment focus
Exhibits65: Eisai Co. Ltd. - Overview
Exhibits66: Eisai Co. Ltd. - Business segments
Exhibits67: Eisai Co. Ltd. - Key offerings
Exhibits68: Eisai Co. Ltd. - Key customers
Exhibits69: Eisai Co. Ltd. - Segment focus
Exhibits70: Fresenius SE and Co. KGaA - Overview
Exhibits71: Fresenius SE and Co. KGaA - Business segments
Exhibits72: Fresenius SE and Co. KGaA - Key offerings
Exhibits73: Fresenius SE and Co. KGaA - Key customers
Exhibits74: Fresenius SE and Co. KGaA - Segment focus
Exhibits75: Hikma Pharmaceuticals Plc - Overview
Exhibits76: Hikma Pharmaceuticals Plc - Business segments
Exhibits77: Hikma Pharmaceuticals Plc - Key offerings
Exhibits78: Hikma Pharmaceuticals Plc - Key customers
Exhibits79: Hikma Pharmaceuticals Plc - Segment focus
Exhibits80: Laboratorios Farmaceuticos Rovi SA - Overview
Exhibits81: Laboratorios Farmaceuticos Rovi SA - Business segments
Exhibits82: Laboratorios Farmaceuticos Rovi SA - Key offerings
Exhibits83: Laboratorios Farmaceuticos Rovi SA - Key customers
Exhibits84: Laboratorios Farmaceuticos Rovi SA - Segment focus
Exhibits85: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Overview
Exhibits86: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Product and service
Exhibits87: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Key offerings
Exhibits88: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Key customers
Exhibits89: Nanjing Kingfriend Biochemical Pharmaceutical Co. Ltd. - Segment focus
Exhibits90: Pfizer Inc. - Overview
Exhibits91: Pfizer Inc. - Business segments
Exhibits92: Pfizer Inc. - Key offerings
Exhibits93: Pfizer Inc. - Key customers
Exhibits94: Pfizer Inc. - Segment focus
Exhibits95: Sanofi SA - Overview
Exhibits96: Sanofi SA - Business segments
Exhibits97: Sanofi SA - Key offerings
Exhibits98: Sanofi SA - Key customers
Exhibits99: Sanofi SA - Segment focus
Exhibits100: Viatris Inc. - Overview
Exhibits101: Viatris Inc. - Business segments
Exhibits102: Viatris Inc. - Key offerings
Exhibits103: Viatris Inc. - Key customers
Exhibits104: Viatris Inc. - Segment focus
Exhibits105: Currency conversion rates for US$
Exhibits106: Research Methodology
Exhibits107: Validation techniques employed for market sizing
Exhibits108: Information sources
Exhibits109: List of abbreviations
